Laurel Junk, vice president of supply chain with Kaiser Permanente, details the transformation that's under way in the hospital industry, driven by healthcare reform and a new focus on the ultimate "customer" - the patient.
Lower-cost "biosimilars" are coming to the U.S. Gillian Woollett, chief scientist with Engel & Novitt LLP, discusses the implications for drug companies, supply-chain managers and patients.
Jim Burleigh, chief executive officer of SmartTurn, talks about the challenges faced by small and medium-sized companies in a time of tight budgets, slow demand and stricter government regulations.
Those specialized sectors, with their need for strict regulatory compliance and product control, have lagged other industries in the use of third-party service providers. But the picture is beginning to change, says Angela Watson, UPS's vice president of enterprise sales for the healthcare sector.
Rod Derifield, chief executive officer of Envirocooler LLC, outlines some of the new ideas and technology that providers are deploying to boost efficiencies in the movement of temperature-controlled pharmaceuticals.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.